Clientelistic Updates in the Middle East: Contrasting Syria and Iraq
Digest of Middle East Studies · 2027-01 · 36 (1)
DOI: 10.1111/dome.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digest of Middle East Studies, online erschienen am 19.11.2026. Verfasst von Ebtisam Hussein und 1 weiteren Autor:innen. Die Arbeit nennt 94 Literaturangaben.
Abstract (Originalsprache)
The key finding of scholarship on clientelistic networks and their role in sustaining MENA ruling regimes is that the latter build and use them to sustain their rule, largely through symbiotic relations of mutual benefit. This would imply a degree of continuity in the relationship. Our central claim challenges the idea of continuity and our argument is that clientelistic updates occur. They follow one of three non‐mutually exclusive practices: altering the proximity and relevance of some clients; adding new elements; or eliminating clients. Conversely, when the regime is dismantled, one would expect the radical and comprehensive elimination of clients, particularly when the new regime democratises. Our article uncovers though that clientelistic practices can survive the fall of the regime, even when regime clients are radically eliminated. Comparing the two cases of Iraq and Syria reveals important insights on regime‐client relations, how they are updated and what their role is in sustaining/undermining ruling regimes.
Zitieren
APA
Hussein, E., & Cavatorta, F. (2027). Clientelistic Updates in the Middle East: Contrasting Syria and Iraq. Digest of Middle East Studies, 36(1). https://doi.org/10.1111/dome.70037
Vancouver
Hussein E, Cavatorta F. Clientelistic Updates in the Middle East: Contrasting Syria and Iraq. Digest of Middle East Studies. 2027;36(1). doi:10.1111/dome.70037
BibTeX
@article{Hussein2027,
author = {Hussein, Ebtisam and Cavatorta, Francesco},
title = {Clientelistic Updates in the Middle East: Contrasting Syria and Iraq},
journal = {Digest of Middle East Studies},
year = {2027},
volume = {36},
number = {1},
doi = {10.1111/dome.70037}
}
EUVIMED